Đang chuẩn bị liên kết để tải về tài liệu:
ID1 mediates resistance to osimertinib in EGFR T790M-positive non-small cell lung cancer through epithelial–mesenchymal transition
Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
ID1 is associated with resistance to the first generation of EGFR tyrosine kinase inhibitors (EGFR-TKIs) in non-small cell lung cancer (NSCLC). However, the effect of ID1 expression on osimertinib resistance in EGFR T790Mpositive NSCLC is not clear. |